This is a preprint.
The association of medical mistrust, clinical trial knowledge, and perceived clinical trial risk with willingness to participate in health research among historically marginalized individuals living in New York City
- PMID: 40630525
- PMCID: PMC12236929
- DOI: 10.21203/rs.3.rs-6699898/v1
The association of medical mistrust, clinical trial knowledge, and perceived clinical trial risk with willingness to participate in health research among historically marginalized individuals living in New York City
Abstract
Medical mistrust, clinical trial knowledge, and clinical trial risk impact research participation, yet are rarely studied among racial and ethnic groups. Data were from a cross-sectional survey (n = 1,788). Multinomial logistic regression models examined associations of medical mistrust, clinical trial knowledge, and clinical trial risk with willingness to participate in health research (Yes, No, Unsure) among Chinese, Korean, South Asian, Haitian, North American Latiné, South American Latiné, and Southwest Asian and North African (SWANA) NYC residents with one model per group Overall, 46.1% of participants reported willingness to participate, ranging from 35.8% (Chinese participants) to 58.7% (South Asian participants). Increased mistrust was associated with less willingness among Chinese (OR: 1.06, 95%CI: 1.00, 1.12) and South American Latiné (OR: 1.15, 95%CI: 1.01, 1.30) participants; more willingness among Haitian participants (OR: 0.87, 95%CI: 0.81, 0.94); more uncertainty among Korean (OR: 1.13, 95%CI: 1.05, 1.22), South Asian (OR: 1.07 95%CI: 1.01, 1.12), and North American Latiné (OR: 1.18, 95%CI: 1.09, 1.27) participants; and less uncertainty among Haitian (OR: 0.91, 95%CI: 0.84, 0.99) and SWANA (OR: 0.91, 95%CI:0.86, 0.97) participants. Knowledge was associated with more willingness for Haitian participants (OR: 2.77, 95%CI: 1.15, 6.65), less willingness for Chinese participants (OR: 0.55, 95%CI: 0.34, 0.88), and more uncertainty among South Asian (OR: 2.09, 95%CI: 1.07, 4.07) and SWANA (OR: 2.71, 95%CI: 1.21, 6.03) participants. Some risk and more willingness were linked for South American Latiné participants (OR: 0.14, 95%CI: 0.02, 0.85). Associations varied by group. Studying diverse groups advances equitable research representation.
Keywords: health disparities; health research knowledge; medical mistrust; perceived research risk; racial and ethnic groups; research participation.
Conflict of interest statement
Additional Declarations: No competing interests reported.
References
-
- Freedman LS, Simon R, Foulkes MA, et al. Inclusion of women and minorities in clinical trials and the NIH Revitalization Act of 1993–the perspective of NIH clinical trialists. Control Clin Trials. Oct 1995;16(5):277–285; discussion 286 – 279, 293–309. - PubMed
-
- Ma MA, Gutiérrez DE, Frausto JM, Al-Delaimy WK. Minority Representation in Clinical Trials in the United States: Trends Over the Past 25 Years. Mayo Clinic Proceedings. 2021;96(1):264–266. - PubMed
-
- Frueh S. Lack of Equitable Representation in Clinical Trials Compounds Disparities in Health and Will Cost U.S. Hundreds of Billions of Dollars; Urgent Actions Needed by NIH, FDA, Others to Boost Representation: National Academies Sciences, Engineering, and Medicine; 2022.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
